Northern Trust Corp Concert Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.34 - $5.84 $1,918 - $2,581	-442 Reduced 0.34%	128,892 $752,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $137,062 - $231,112	32,099 Added 33.01%	129,334 $866,000
Q2 2022 Aug 12, 2022	SELL	$2.8 - $6.36 $5,591 - $12,700	-1,997 Reduced 2.01%	97,235 $410,000
Q1 2022 May 13, 2022	SELL	$2.73 - $3.94 $3,619 - $5,224	-1,326 Reduced 1.32%	99,232 $334,000
Q4 2021 Feb 08, 2022	SELL	$2.69 - $4.22 $12,433 - $19,504	-4,622 Reduced 4.39%	100,558 $317,000
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $21,112 - $27,639	-6,660 Reduced 5.95%	105,180 $344,000
Q2 2021 Aug 13, 2021	SELL	$3.77 - $5.24 $851,160 - $1.18 Million	-225,772 Reduced 66.87%	111,840 $473,000
Q1 2021 May 12, 2021	SELL	$4.86 - $13.07 $279,377 - $751,328	-57,485 Reduced 14.55%	337,612 $1.68 Million
Q4 2020 Feb 11, 2021	SELL	$9.48 - $12.84 $102,820 - $139,262	-10,846 Reduced 2.67%	395,097 $4.99 Million
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $59,510 - $74,268	-6,864 Reduced 1.66%	405,943 $3.99 Million
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $611,348 - $902,914	78,378 Added 23.44%	412,807 $4.11 Million
Q1 2020 May 14, 2020	BUY	$5.98 - $13.09 $305,745 - $669,265	51,128 Added 18.05%	334,429 $2.96 Million
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $109,706 - $177,143	-19,213 Reduced 6.35%	283,301 $2.61 Million
Q3 2019 Nov 13, 2019	BUY	$5.88 - $12.35 $39,737 - $83,461	6,758 Added 2.28%	302,514 $1.78 Million
Q2 2019 Aug 13, 2019	BUY	$9.44 - $13.12 $44,226 - $61,467	4,685 Added 1.61%	295,756 $3.55 Million
Q1 2019 May 13, 2019	BUY	$12.07 - $17.54 $1,810 - $2,631	150 Added 0.05%	291,071 $3.51 Million
Q4 2018 Feb 12, 2019	SELL	$11.25 - $16.17 $2.11 Million - $3.03 Million	-187,269 Reduced 39.16%	290,921 $3.65 Million
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $2.5 Million - $3.49 Million	-195,276 Reduced 29.0%	478,190 $7.1 Million
Q2 2018 Sep 18, 2018	SELL	$16.83 - $21.66 $24,521 - $31,558	-1,457 Reduced 0.22%	673,466 $11.3 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $653,441 - $840,971	38,826 Added 6.1%	674,923 $11.4 Million
Q1 2018 May 09, 2018	BUY	$19.24 - $28.03 $3.83 Million - $5.58 Million	199,090 Added 45.56%	636,097 $14.6 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $2.85 Million - $5.92 Million	203,806 Added 87.39%	437,007 $11.3 Million
Q3 2017 Nov 13, 2017	BUY	$13.91 - $15.31 $3.24 Million - $3.57 Million	233,201	233,201 $3.44 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account